King's College London

Research portal

Oxidative stress biomarkers in four Bloom syndrome (BS) patients and in their parents suggest in vivo redox abnormalities in BS phenotype

Research output: Contribution to journalArticlepeer-review

A Zatterale, F J Kelly, P Degan, M d'Ischia, F V Pallardo, R Calzone, C Dunster, A Lloret, P Manini, O Cogulu, K Kavakli, G Pagano

Original languageEnglish
Pages (from-to)1100 - 1103
Number of pages4
JournalClinical Biochemistry
Issue number15
PublishedOct 2007

King's Authors


objective: To evaluate an association of Bloom syndrome (BS) phenotype with an in vivo prooxidant state. Methods: The following endpoints were measured in 4 BS patients, their 6 parents, and 78 controls: a) leukocyte and urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG);b) blood glutathione (GSSG and GSH), c) plasma levels of some plasma antioxiclants (uric acid, UA, ascorbic acid, AA alpha- and gamma-tocopherol), and of glyoxal (Glx) and methylglyoxal (MiGlx). Results: Leukocyte S-OHdG levels were significantly increased in the 4 BS patients vs. 40 controls (p=0.04), while the urinary 8-OHdG levels were non-significantly increased in BS patients. Glutathione disulfide levels and GSSG/GSH ratio were significantly decreased in BS patients vs. 44 controls (p 0.02). The plasma levels of UA in BS patients were significantly increased vs. 24 controls (p=0.005). No significant alterations were found in the in the plasma levels of Glx, MGlx, AA, and tocopherol. No changes in the tested parameters were found in the BS heterozygotes. Conclusion: This report shows a significant increase in oxidative DNA damage in leukocytes and in plasma UA levels from 4 BS patients. Should these data be confirmed in more extensive BS patient groups, an involvement of oxidative stress in the clinical BS phenotype might be suggested. (c) 2007 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454